Top 7 protocols |
Jump straight into running your experiments and getting results. Essential protocols for all new researchers. |
|
|
|
|
|
|
|
|
![Your product recommendation](https://blogger.googleusercontent.com/img/proxy/AVvXsEi3ntb6ElDTw9wsRn0953PkY6A0lzZaTWA-oBjTCkGSOiLheMMWhjxAl4PWU93vMimBuXM5Pq0Kk8cG6KnoU1X6SXJ1k9fYypGR6_Hxowgp4wmDftz0sMp0BeK52LuXlqxpgo0JCSUWFSN3_qyRyFJxF1G8A791oEiC45vD7DsSN3dPu_MvOO5RcJe3dKxxcwjm_r0HMqAmzQ4zM-BCwXWLtrYQLWhsYNu-eBWDNNOts6ImzWlc2fbcyyc99NydLpVaQ3PieSA34JvKQKW6mGaGV46Y9_VB9017s7UrHf70w11BEV2tCq74=s0-d-e1-ft&Species=&Research+Area+-+Epigenetics=%0D&Research+Area+-+Neuroscience=Yes&Research+Area+-+Cancer=Yes) |
|
|
|
|
Ki67: cleaner data, less antibody |
Get better IHC results with less background and using less antibody. Our KO-validated Ki67 antibodies outperform the competition. |
|
|
|
|
|
|
|
IHC for paraffinized sections |
Watch our lab team demonstrate IHC for paraffin-embedded sections in only five minutes. |
|
|
|
|
|
|
|
One-biomarker-per-drug paradigm |
Discover why one-biomarker-per-drug is insufficient and how combination biomarkers could aid to meet this challenge. |
|
|
|
|
|
|
|
BRAF and MEK inhibitors in melanoma treatment |
Find out how BRAF V600E and immune target combination therapies are at the forefront of melanoma research. |
|
|
|
|
|
No hay comentarios:
Publicar un comentario